BNP PARIBAS announced Evonik Industries (ETR:EVK), bumping its price target to 28.00EUR earlier today
- Updated: September 16, 2016
Only yesterday Evonik Industries (ETR:EVK) traded 4.60% lower at 29.09EUR. Evonik Industries’s 50-day average is 2.55EUR and its 200-day moving average is 2.03EUR. The last close is up 12.06% relative to the two hundred day average, compared with the Standard & Poor’s 500 Index which has decreased -0.01% over the same period. Trade volume was was up over the average, with 12,913 shares of EVK changing hands over the typical 6,964 shares..
BNP PARIBAS upped the target price of Evonik Industries (ETR:EVK) to 28EUR, indicating a possible downside of -0.04%,
On 9/08/2016, Deutsche Bank AG reported on Evonik Industries(ETR:EVK) bumped the target price from 0.00EUR to 31.00EUR. At the time, this suggested an upside of 0.02%.
With a total market value of 0.0 EUR, Evonik Industries has a PE of 3 with a one-year low of 1.35EUR and a one-year high of 3.28EUR.
About Evonik Industries (ETR:EVK)
Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company’s activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company’s sites, and among others. It is a subsidiary of RAG Stiftung.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.